Anti-cancer antibodies with reduced complement fixation

Details for Australian Patent Application No. 2005206277 (hide)

Owner Merck Patent GmbH

Inventors Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-B-2005206277

PCT Pub. Number WO2005/070967

Priority 60/538,348 22.01.04 US

Filing date 18 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 23 June 2011

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/070967 Priority application(s): WO2005/070967

23 June 2011 Application Accepted

  Published as AU-B-2005206277

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206278-End cover

2005206275-Slide rail